A proton magnetic resonance spectroscopic study in ALS: correlation with clinical findings
This new semaglutide dose helped nearly half of patients lose 20% body weight Date: October 4, 2025 Source: The Lancet Summary: The STEP UP trials revealed that a 7.2 mg dose of semaglutide led to greater weight loss than the currently approved 2.4 mg dose
Under the direction of Chikodiri Gibson, DNP, MBA, FNP-C, and open six days a week
A comprehensive review of GLP-1 and aerobic training in cardiovascular disease management
Genetic screen results are shared in Supplementary Tables 7 and 8
At Grand Health Partners, we provide structured medical programs built around clinical oversight, accountability, and long-term strategy, not quick fixes or unsupervised dieting